The Oncology Institute, Inc. TOI Other assets — Total Assets
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other assets — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other assets — total assets?
- The Oncology Institute, Inc. (TOI) reported other assets — total assets of $42.77M in Q1 2026.
- How has The Oncology Institute, Inc.'s other assets — total assets changed year-over-year?
- The Oncology Institute, Inc.'s other assets — total assets increased by 42.1% year-over-year, from $30.09M to $42.77M.
- What does other assets — total assets mean?
- This metric represents the book value of assets held within the 'Other' operating segment relative to the company's total asset base. It captures resources allocated to non-core activities or miscellaneous business functions that do not fall under primary dispensary, patient services, or clinical trial segments. Monitoring this ratio helps investors assess the capital intensity of ancillary business lines and the potential for asset impairment or reallocation.